Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications. - Lenferink AEG; Zwaagstra JC; Baardsnes J; Delafosse L; Parat M; Iqbal U; Lessard E; Haqqani AS; Jezierski A; Abu-Thuraia A; Tabariès S; Siegel PM; et al. (Frontiers in oncology, 2025)